BRCA1 and neoplasm: Our findings also suggest that targeting this newly discovered fork recovery pathway might represent a promising strategy to selectively kill BRCA1-deficient tumor cells (Figure 6C) and highlight the possible predictive utility of measuring levels of these fork recovery factors in tumor samples.